Quantinuum Inc. (QNT) Income Statement
QNT 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsQNT revenue and net income
Where QNT's revenue goes
2025Each bar shows an amount and its share of revenue. QNT kept −231.3% of revenue as net income.
QNT profit margins
QNT growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +34.6% | — | — | — |
| Gross profit | +58.0% | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
QNT quarterly EPS vs estimates
Quantinuum beat the analyst EPS estimate in 0 of the last 1 quarters. Next report: November 10, 2026 (estimate $-1.17).
QNT income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | $30.9M | $23.0M |
| Cost of revenue | $11.7M | $10.8M |
| Gross profit | $19.2M | $12.2M |
| Research & development | $405.2M | $122.2M |
| Sales, general & admin | $132.7M | $31.3M |
| Total operating expenses | $549.3M | $164.9M |
| Operating income | −$530.1M | −$152.8M |
| Interest income | $12.7M | $10.0M |
| Income before taxes | −$568.0M | −$143.8M |
| Income taxes | $75,000 | $233,000 |
| Net income | −$71.5M | −$144.1M |
| EBITDA | −$538.2M | −$111.6M |
| EPS (diluted) | −$2.06 | — |
| Gross margin | 62.2% | 53.0% |
| Operating margin | −1,713.7% | −664.8% |
| Net margin | −231.3% | −627.0% |
| Jun '26 | Mar '26 | Jun '25 | Mar '25 | |
|---|---|---|---|---|
| Revenue | $8.0M | $5.2M | $2.1M | $19.1M |
| Cost of revenue | $10.3M | $1.8M | $1.2M | $1.5M |
| Gross profit | −$2.3M | $3.4M | $903,000 | $17.6M |
| Research & development | $367.3M | $74.7M | $39.7M | $35.8M |
| Sales, general & admin | $181.2M | $62.2M | $9.5M | $8.9M |
| Total operating expenses | $552.7M | $141.1M | $52.0M | $47.5M |
| Operating income | −$555.0M | −$137.7M | −$51.1M | −$29.9M |
| Interest income | $4.7M | $4.8M | $999,000 | $1.3M |
| Income before taxes | −$596.0M | −$132.9M | −$56.9M | −$30.3M |
| Income taxes | $569,000 | $48,000 | — | $183,000 |
| Net income | −$175.5M | −$16.7M | −$56.9M | −$30.5M |
| EBITDA | −$545.5M | −$124.0M | −$43.4M | −$23.1M |
| EPS (diluted) | −$0.28 | — | — | — |
| Gross margin | −28.9% | 65.1% | 42.8% | 92.3% |
| Operating margin | −6,939.6% | −2,628.9% | −2,423.5% | −156.6% |
| Net margin | −2,194.4% | −319.6% | −2,700.0% | −159.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in QNT's financial statements (latest annual report filed December 31, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
QNT financial results
In fiscal year 2025 (ended December 31, 2025), Quantinuum reported revenue of $30.9 million, up 34.6% from the year before. It had a net loss of $71.5 million, a net profit margin of −231.3%. Diluted earnings per share came to −$2.06.
See the QNT stock overview for the latest quote and news, or the QNT chart for price history and technical indicators.
QNT income statement FAQ
What is Quantinuum's annual revenue?
Quantinuum reported total revenue of $30.9 million for fiscal year 2025, which ended on December 31, 2025. That was up 34.6% from $23.0 million the previous year.
Is Quantinuum profitable?
No. Quantinuum reported a net loss of $71.5 million in fiscal 2025, a net profit margin of −231.3%; its operating margin was −1,713.7%.
What is Quantinuum's gross margin?
Quantinuum's gross margin was 62.2% in fiscal 2025: for every $100 of revenue, Quantinuum kept $62 after the direct cost of its products and services.
How much does Quantinuum spend on research and development?
Quantinuum spent $405.2 million on research and development in fiscal 2025, 1,310.2% of revenue.
What are Quantinuum's earnings per share?
Quantinuum earned $-2.06 per diluted share in fiscal 2025.
When will Quantinuum report its next earnings?
Quantinuum is expected to report results for the quarter ending September 30, 2026 on November 10, 2026.
When does Quantinuum's fiscal year end?
Quantinuum's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on December 31, 2025.